News on molecular diagnostics, pharmacogenomics tests for coronary artery disease, congenital heart defects, and more.
The research institute will provide blood samples to Prevencio, which will then use its artificial intelligence platform to develop a diagnostic test.
Fosun Pharma said its kit detects novel coronavirus RNA targeting the ORF1ab, N, and E genes, and it can test 96 samples within two hours.
Prevencio said that the agreement with Microsoft involves sales of cardiac blood tests to hospitals, life science companies, and contract research organizations.
The Ottawa-based molecular diagnostics maker also plans to enter applied markets in the near term, and ultimately point-of-care infectious disease testing.
The Milwaukee, Wisconsin-based firm is part of a growing biotech ecosystem in the region, which has particular expertise in transplant medicine.
